Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 391 across all filing types
Latest filing 2024-03-28 AGM Information
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
상호변경안내
AGM Information Classification · 100% confidence The document is a formal announcement regarding a change of company name (from Medifron DBT to Hyper Corporation). It provides details on the change, the reason, and the date of the shareholder meeting where this was approved. Since this is a regulatory announcement regarding corporate structure/identity that does not fit into specific categories like M&A, Board changes, or financial reports, it is classified as a general regulatory filing.
2024-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of an outside director (사외이사). This falls under the category of changes in the board of directors or senior management.
2024-03-28 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing and incoming directors, the reason for the change (resignation), the date of the board resolution, and the professional background of the new appointee. This falls directly under the category of board and management changes.
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion (unqualified/appropriate), key financial data, and details regarding the auditor. According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 27th fiscal year (2023) of Medifron DBT Co., Ltd. It contains comprehensive information including company overview, business activities, financial statements, management analysis, and governance details. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2023
2024-03-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-03-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.